Abstract
Homeostatic control of synaptic efficacy is often mediated by dynamic regulation of excitatory synaptic receptors. Here, we report a novel form of homeostatic synaptic plasticity based on regulation of shunt currents that control dendritosomatic information transfer. In cortical pyramidal neurons from wild-type mice, HCN1 channels underlie a dendritic hyperpolarization-activated cationic current (I(h)) that serves to limit temporal summation of synaptic inputs. In HCN1 knock-out mice, as expected, I(h) is reduced in pyramidal neurons and its effects on synaptic summation are strongly diminished. Unexpectedly, we found a markedly enhanced bicuculline- and L-655,708-sensitive background GABA(A) current in these cells that could be attributed to selective upregulation of GABA(A) alpha5 subunit expression in the cortex of HCN1 knock-out mice. Strikingly, despite diminished I(h), baseline sublinear summation of evoked EPSPs was unchanged in pyramidal neurons from HCN1 knock-out mice; however, blocking tonic GABA(A) currents with bicuculline enhanced synaptic summation more strongly in pyramidal cells from HCN1 knock-out mice than in those cells from wild-type mice. Increasing tonic GABA(A) receptor conductance in the context of reduced I(h), using computational or pharmacological approaches, restored normal baseline synaptic summation, as observed in neurons from HCN1 knock-out mice. These data indicate that upregulation of alpha5 subunit-mediated GABA(A) receptor tonic current compensates quantitatively for loss of dendritic I(h) in cortical pyramidal neurons from HCN1 knock-out mice to maintain normal synaptic summation; they further imply that dendritosomatic synaptic efficacy is a controlled variable for homeostatic regulation of cortical neuron excitability in vivo.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
-
Animals
-
Anti-Anxiety Agents / pharmacology
-
Bicuculline / pharmacology
-
Cerebral Cortex / cytology*
-
Cyclic Nucleotide-Gated Cation Channels / antagonists & inhibitors
-
Cyclic Nucleotide-Gated Cation Channels / deficiency*
-
Cyclic Nucleotide-Gated Cation Channels / physiology*
-
Desoxycorticosterone / analogs & derivatives
-
Desoxycorticosterone / pharmacology
-
Excitatory Amino Acid Antagonists / pharmacology
-
Excitatory Postsynaptic Potentials / drug effects
-
Female
-
GABA Agents / pharmacology
-
Homeostasis / genetics
-
Homeostasis / physiology
-
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
-
Male
-
Membrane Potentials / drug effects
-
Membrane Potentials / physiology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Models, Neurological
-
Patch-Clamp Techniques / methods
-
Potassium Channels / deficiency*
-
Potassium Channels / physiology*
-
Protein Subunits / genetics
-
Protein Subunits / metabolism
-
Pyramidal Cells / physiology*
-
Pyridazines / pharmacology
-
Pyrimidines / pharmacology
-
Receptors, GABA-A / physiology*
-
Sodium Channel Blockers / pharmacology
-
Synapses / physiology*
-
Tetrodotoxin / pharmacology
-
Up-Regulation / drug effects
-
Up-Regulation / genetics
-
Valine / analogs & derivatives
-
Valine / pharmacology
Substances
-
Anti-Anxiety Agents
-
Cyclic Nucleotide-Gated Cation Channels
-
Excitatory Amino Acid Antagonists
-
GABA Agents
-
Hcn1 protein, mouse
-
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
-
Potassium Channels
-
Protein Subunits
-
Pyridazines
-
Pyrimidines
-
Receptors, GABA-A
-
Sodium Channel Blockers
-
ICI D2788
-
Desoxycorticosterone
-
Tetrodotoxin
-
tetrahydrodeoxycorticosterone
-
6-Cyano-7-nitroquinoxaline-2,3-dione
-
2-amino-5-phosphopentanoic acid
-
gabazine
-
Valine
-
Bicuculline